The largest database of trusted experimental protocols

4 protocols using recombinant bmp 2

1

Co-Immunoprecipitation of BMP-2/4 Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
Co-IP assays were performed using conditioned media from hVSMCs cultured in the presence of 500 ng/ml of recombinant BMP-2 (Preprotech) for 24 h in M199 with 10% FBS, and the Dynabeads Co-immunoprecipitation Kit (Novex, Life Technologies), according to manufacturer’s recommendations. The BMP-2/4 monoclonal (Santa Cruz Biotechnology, sc-137087) and negative IgG antibodies were used as capture antibodies in the Co-IP reactions, and Western blot analysis of the eluted proteins were performed using CTerm-Ucma/GRP (GenoGla Diagnostics, Faro, Portugal) and BMP-2/4 antibodies as described above.
+ Open protocol
+ Expand
2

Analyzing Signaling Pathways in BMP-Mediated Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-p-p65, anti-p65, anti-p-ERK1/2, anti-ERK1/2, anti-p-AKT, and anti-AKT were purchased from Cell Signaling Technology (Boston, MA, USA). Anti-GAPDH antibody was purchased from the ProteinTech Group (Chicago, IL, USA). Anti-BMP2, anti-BMP4, anti-BMPRIa, anti-BMPRII, anti-BMPRIb, and anti-occludin antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Recombinant BMP2, BMP4, and noggin were purchased from Peprotech (NJ, USA). The inhibitor of NF-κB, PDTC, was purchased from Beyotime (Wuhan, China).
+ Open protocol
+ Expand
3

Fabrication and Characterization of BMP-2-Loaded Collagen Scaffold

Check if the same lab product or an alternative is used in the 5 most similar protocols
Collagen solution (collagen: BD, USA; HEPES: Gibco®, USA; 1 N NaOH: Gibco®, USA; HBSS: Gibco® USA) was mixed with recombinant BMP-2 (1 μg/ml, PeproTech, Rocky Hill, NJ, USA) or PBS solution. After cultivating in an incubator for 12 h at 37 °C, further incubation was done at − 80 °C for 12 h in a deep freezer. Thereafter, a collagen sheet was fabricated by using a lyophilizer. Collagen sheet (width 10 mm, thickness 0.5 mm) was inserted into the calvarial defect area. Control (PBS-loaded) or BMP-2-loaded collagen scaffolds were used in experiments on cranial bone regeneration models.
Scanning electron microscopy (SEM, JSM-6700F, Jeol, Tokyo, Japan) was performed on the external surface of the collagen scaffold. Photographs were taken at a magnification of ×1,000 and ×10,000.
In vitro BMP-2 release from the BMP-2-loaded collagen scaffold (BMP-2, 1 μg/ml) was evaluated using a commercially available ELISA kit (Quantikine®, R&D systems, Minneapolis, MN, USA). A 10 mm × 10 mm-size BMP-2-loaded collagen scaffold (BMP-2, 1 μg/ml) was cut and immersed in 1 ml PBS (pH 7.4) solution. The amount of release of BMP-2 protein into the media at indicated time points was measured (n = 4).
+ Open protocol
+ Expand
4

DNA Damage Response in Myogenic Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All treatments and differentiation were performed in GM. Idoxuridine (IdU) and bromo-deoxyuridine (BrdU) were purchased from Sigma-Aldrich (#I7125, #B5002) and dissolved in DMSO at final concentration of 25 mM. Thymidine (Sigma-Aldrich, #T5018) and uridine (Sigma-Aldrich, #U3750) were dissolved in PBS at final concentration of 25 mM. Recombinant BMP-2 were purchased from Pepro-Tech (#120–02) and prepared according to manufacturer’s instructions to final concentration of 200 μg/ml. Experimental concentrations are indicated in Figure legends and Results.
Spontaneous myogenic differentiation was obtained by incubating the cells for additional 5 days after reaching confluence.
The induction of DNA damage was performed by treating cells with 0.5 μM Etoposide (Teva Pharmaceuticals) or 0.5 μM Doxorubicin (Sigma Aldrich, #D1515) for 24 hours. Cisplatin was purchased from Hospira (Lot #Y091881AB; Brussel, Belgium) and used at final concentration of 0.5 μM.
ATM and p38 kinase inhibitors, KU 55933 (Tocris Bioscience, #3544) or SB 203580 (Sigma Aldrich, #S8307) respectively, were used at 10 μM in pre-treatment for 3 hours followed by co-treatment with IdU for the indicated time.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!